Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention
Yue Li, Chi Qin, Chenxu Miao, Ronghao Mu, Penghua Zhang, Bohao Zhang, Xin Zhao, Xiaoan Zhang · 2026
Read Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention by Yue Li, Chi Qin, Chenxu Miao, Ronghao Mu, Penghua Zhang, Bohao Zhang, Xin Zhao, Xiaoan Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13303037.txt.
Description
A sugar-burning enzyme in immune cells helps drive newborn brain injury, Yue Li and colleagues identify in a 2026 study of hypoxic-ischemic brain damage. Gene-network mining of public datasets singled out hexokinase 2 among glycolysis genes, and a mouse model confirmed the enzyme surging within a day of injury, mostly inside microglia. Blocking it early with the inhibitor 3-bromopyruvate tested causality.
Treated mice showed smaller infarcts, better neurological scores, less lactate buildup, and quieter inflammatory signals. A single early dose still protected brain tissue and behavior thirty days later. The authors nominate the hexokinase-glycolysis axis as an early-intervention target where cooling therapy often falls short.
Catalog record
| CREATOR | Yue Li, Chi Qin, Chenxu Miao, Ronghao Mu, Penghua Zhang, Bohao Zhang, Xin Zhao, Xiaoan Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48756 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |